Company intelligence / Profile preview

GOC Nexus GmbH

Laupheim, Baden-Württemberg, Germanyuk.marketscreener.com ↗

Ownership: Private
Development stage: Preclinical

Overview

GOC Nexus has developed and validated a patented cold plasma sterilization process that effectively eliminates microbial contamination from cannabis without compromising its chemical profile. Independent tests confirm preservation of cannabinoids, terpenes, taste, and aroma. The process is EU-GMP compliant and ready for commercial scale-up with production facilities in Canada operational by late 2024 and an EU-GMP certified facility in Germany expected by mid-2025[2][3][5].

Modalities: Device (cold plasma sterilization technology)
Industry: Contract Manufacturing Organization

Partnerships

BTAB Solutions Inc. (joint development/financing/operations partner for Canadian/EU processing hubs)[3][6]SynBiotic SE (strategic investment & partnership to optimize European operations)[5]

Beyond the preview

Go deeper on GOC Nexus GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GOC Nexus GmbH.

Explore the full profile